全球免疫球蛋白市场规模、份额、趋势和成长分析报告（2026-2034年）

预计免疫球蛋白市场将从 2025 年的 239.4 亿美元成长到 2034 年的 417 亿美元，2026 年至 2034 年的复合年增长率为 6.36%。

受免疫不全症和自体免疫疾病日益普遍的推动，全球免疫球蛋白市场正经历强劲成长。免疫球蛋白是重要的血浆衍生疗法，用于增强免疫力并治疗多种神经系统和血液系统疾病。诊断率的提高和人们对罕见疾病认识的增强也显着促进了全球需求的成长。

血浆分馏技术的进步和捐赠者网络的扩张是推动市场成长要素。新适应症的核准和健保报销政策的改善也进一步促进了市场成长。此外，医疗保健支出的增加和生物製药生产投资的加大也为免疫球蛋白产品的全球大规模生产和分销提供了支持。

随着研究不断探索更多治疗应用，未来前景依然强劲。新兴市场可望凭藉医疗基础设施和诊断能力的提升，带来巨大的发展机会。皮下注射免疫球蛋白製剂和居家静脉输液疗法等创新技术将提升病患就医便利性，并推动市场长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球免疫球蛋白市场：依应用划分

• 市场分析、洞察与预测
• 神经病学
• 免疫学
• 血液学
• 其他的

第五章：全球免疫球蛋白市场：依给药途径划分

• 市场分析、洞察与预测
• 静脉注射
• 皮下注射
• 肌肉内注射

第六章 全球免疫球蛋白市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 诊所
• 居家照护

第七章 全球免疫球蛋白市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Shire
  • CSL Behring
  • Kedrion Biopharma Inc
  • Grifols SA
  • Octapharma
  • China Biologic Products Holdings Inc
  • Biotest AG
  • Sanquin
  • LFB SA

The Immunoglobulins Market size is expected to reach USD 41.70 Billion in 2034 from USD 23.94 Billion (2025) growing at a CAGR of 6.36% during 2026-2034.

The Global Immunoglobulins Market is experiencing strong growth driven by increasing prevalence of immune deficiency disorders and autoimmune diseases. Immunoglobulins are essential plasma-derived therapies used to boost immunity and treat various neurological and hematological conditions. Growing diagnosis rates and improved awareness of rare diseases are significantly contributing to rising demand worldwide.

Key growth drivers include advancements in plasma fractionation technologies and expanding donor networks. Increasing approvals for new therapeutic indications and improved reimbursement policies are further strengthening market expansion. Additionally, rising healthcare spending and growing investments in biologics manufacturing are supporting large-scale production and distribution of immunoglobulin products globally.

Future prospects appear robust as research continues to explore additional therapeutic applications. Emerging markets are expected to offer substantial opportunities due to improving healthcare infrastructure and diagnostic capabilities. Innovations in subcutaneous immunoglobulin formulations and home-based infusion therapies will likely enhance patient convenience and drive long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Neurology
• Immunology
• Hematology
• Others

By Route of Administration

• Intravenous
• Subcutaneous
• Intramuscular

By End-user

• Hospitals
• Clinics
• Homecare

COMPANIES PROFILED

• Shire, CSL Behring, Kedrion Biopharma Inc, Grifols SA, Octapharma, China Biologic Products Holdings Inc, Biotest AG, Sanquin, LFB SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMMUNOGLOBULINS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMMUNOGLOBULINS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Intravenous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Subcutaneous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Intramuscular Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMMUNOGLOBULINS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMMUNOGLOBULINS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Route Of Administration
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Route Of Administration
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Route Of Administration
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Route Of Administration
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Route Of Administration
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IMMUNOGLOBULINS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Shire
  • 9.2.2 CSL Behring
  • 9.2.3 Kedrion Biopharma Inc
  • 9.2.4 Grifols S.A
  • 9.2.5 Octapharma
  • 9.2.6 China Biologic Products Holdings Inc
  • 9.2.7 Biotest AG
  • 9.2.8 Sanquin
  • 9.2.9 LFB SA